Comparable stake leader
Accelmed Partners, L.P.
SEC ownership of STRATA Skin Sciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001051514.
Disclosed value leader
Accelmed Partners, L.P.
Comparable rows
4/19
Latest evidence
17 Nov 2025
- Public ticker
- SSKN on OTC
- Parsed ownership sources
- 3/4/5 and 13D/G
- Largest SEC-reported holder
- Accelmed Partners, L.P.
- Latest 13D/G holder
- Accelmed Partners, L.P.
- Latest parsed ownership date
- 17 Nov 2025
- Issuer CIK
- 0001051514
- Issuer location
- Horsham, PA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of STRATA Skin Sciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Accelmed Partners, L.P.
Disclosed value leader
Accelmed Partners, L.P.
Comparable rows
4/19
Latest evidence
17 Nov 2025
3/4/5
13D/G
Lead comparable stake: 27%
15 rows are not safely comparable across share classes.
13D/G row: Accelmed Partners, L.P.
Showing 1-8 of 19 holder rows.
Quick read
Accelmed Partners, L.P. leads the comparable SEC ownership view at 27%.
4 of 19 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Accelmed Partners, L.P.'s linked filing trail.
Comparable ownership
Top 4
Accelmed Partners, L.P.
27%
Nantahala Capital Management, LLC
9.7%
Lincoln Alternative Strategies LLC
6.9%
Samuel Rubinstein
0.17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 19 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Accelmed Partners, L.P. |
3/4/5
13D/G
10%+ Owner
|
27%
from 13D/G
|
$18,109,448
5,767,340 shares
|
— | 15 Jul 2024 |
| Nantahala Capital Management, LLC |
13D/G
|
9.7%
|
$1,034,028
403,917 shares
|
$0 | 30 Sep 2024 |
| Lincoln Alternative Strategies LLC |
13D/G
|
6.9%
|
$695,113
365,849 shares
|
$0 | 03 Sep 2025 |
| Samuel Rubinstein |
3/4/5
Director
|
0.17%
|
$12,360
8,766 shares
|
-$11,776 | 17 Nov 2025 |
| Uri Geiger |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$4,527,362
1,441,835 shares
|
— | 15 Jul 2024 |
| 22NW, LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,718,385
5,369,954 shares
|
— | 16 Aug 2023 |
| Dolev Rafaeli |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$449,510
375,713 shares
mixed-class rows
|
— | 13 May 2025 |
| Nachum Shamir |
3/4/5
Director
|
—
class O/S missing
|
$136,239
289,871 shares
|
— | 05 Jul 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$11,776.
Buys
$7,028
Insiders: 1
Sells
$18,804
Insiders: 1
Net
-$11,776
Shares: -9,094
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 5,000
Shares: 14,094
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 5,000 | 14,094 | $7,028 | $18,804 | -$11,776 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to STRATA Skin Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Accelmed Partners, L.P.
Net 12M change
-$11,776
Latest report
17 Nov 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Accelmed Partners, L.P. | 10%+ Owner | $18,109,448 | Mixed | 15 Jul 2024 | ||
| Uri Geiger | Director, 10%+ Owner | $4,527,362 | Filing P/S | 15 Jul 2024 | ||
| 22NW, LP | 10%+ Owner | $1,718,385 | Mixed | 16 Aug 2023 | ||
| Dolev Rafaeli | Chief Executive Officer, Director | $449,510 | Filing P/S | 13 May 2025 | ||
| Nachum Shamir | Director | $136,239 | Mixed | 05 Jul 2023 | ||
| Robert Joseph Moccia | Chief Executive Officer, Director | $110,591 | Mixed | 10 Aug 2023 | ||
| LuAnn Via | Director | $75,454 | Mixed | 20 Jul 2021 | ||
| William D. Humphries | Director | $51,570 | Mixed | 05 Jul 2023 | ||
| Patricia S. Walker | Director | $42,250 | Mixed | 05 Jul 2023 | ||
| Douglas Strang | Director | $40,832 | Mixed | 05 Jul 2023 | ||
| Christopher Lesovitz | Chief Financial Officer | $17,993 | Mixed | 22 Nov 2023 | ||
| Samuel Rubinstein | Director | $12,360 | -$11,776 | -49% | Filing P/S | 17 Nov 2025 |
| Shmuel Gov | Chief Operating Officer | Mixed | 13 May 2025 | |||
| Christina L. Allgeier | Director | Mixed | 29 Oct 2024 | |||
| Gillings John T. | Chief Accounting Officer | Mixed | 13 May 2025 | |||
| Wayne Cafran | Director | Mixed | 26 Oct 2023 | |||
| Irit Yaniv | Director | Mixed | 26 Oct 2023 |
Recent insider transactions for STRATA Skin Sciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Samuel Rubinstein | SSKN | Common Stock | Purchase | 132.8% | $7,028 | $1.41 | 5,000 | 8,766 | 18 Nov 2025 | Direct |
| Samuel Rubinstein | SSKN | Common Stock | Sale | -78.9% | $18,804 | $1.33 | -14,094 | 3,766 | 17 Nov 2025 | Direct |
* marks a reported price that did not pass the local price check.